The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / 2015 ACR Guideline for the Treatment of Rheumatoid Arthritis Now Available

2015 ACR Guideline for the Treatment of Rheumatoid Arthritis Now Available

November 10, 2015 • By American College of Rheumatology

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The American College of Rheumatology (ACR) announced the availability of its 2015 Guideline for the Treatment of Rheumatoid Arthritis (RA) during the 2015 ACR/ARHP Annual Meeting in San Francisco. An early draft of the recommendations was presented at last year’s meeting in Boston, and the final recommendations are now available on the ACR website. The guideline is designed for use by both rheumatologists and other clinicians for pharmacologic treatment decisions in commonly encountered clinical situations. Included recommendations address:

You Might Also Like
  • 2015 ACR Guideline for the Treatment of Rheumatoid Arthritis
  • ACR Seeks Partners for Rheumatoid Arthritis Guideline Project
  • 2014 ACR/ARHP Annual Meeting: Rheumatoid Arthritis Management Treatment Recommendations
  • The use of DMARDs, biologics, tofacitinib and glucocorticoids in patients with early RA (less than six months) and established RA (six months or more),
  • Recommendations on using a treat-to-target approach, tapering and discontinuing medications;
  • The use of biologics and DMARDs in high-risk RA patients with comorbidities (i.e., hepatitis, congestive heart failure, malignancy and serious infections);
  • The use of vaccines in patients starting/receiving DMARDs or biologics;
  • Screening for tuberculosis in patients starting/receiving biologics or tofacitinib; and
  • Laboratory monitoring for traditional DMARDs.

“The guideline includes recommendations designed to serve as a guide for patients and physicians to discuss evidence-based treatment options and collectively determine the best course of action for their care,” explained Jasvinder Singh, MD, MPH, a rheumatologist at the University of Alabama who served as principal investigator for the guideline project. “They address what we [the guideline development team] felt were the most common clinical scenarios physicians face when treating RA and helping patients manage the condition.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Of the recommendations included, 23% are strong and 77% are conditional. A strong recommendation means the panel was confident that the desirable effects of following the recommendation outweighed the undesirable effects (or vice versa), so the course of action would apply to most patients, and only a small proportion would not want to follow the recommendation. A conditional recommendation means the desirable effects of following the recommendation probably outweigh the undesirable effects, so the course of action would apply to the majority of patients, but some may not want to follow the recommendation. Because of this, conditional recommendations are preference-sensitive and always warrant a shared decision-making approach between clinicians and patients.

Singh notes there a few differences between the development of the 2015 guidelines and previous ACR RA guidelines.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“The new guideline was developed using the GRADE methodology [Grading of Recommendations Assessment, Development and Evaluation], because it provides an internationally accepted systematic approach to guideline development. Important features of the GRADE method include the very clear specification of patient groups, interventions, competing treatment alternatives and outcomes; grading the quality of the evidence used; and basing recommendation strength on evidence quality, balance of benefits and harms, patient preference of treatment options, as well as clinical experience and expertise.”

The ACR plans to develop a pocket card, an app version of the guideline and a patient education tool to facilitate implementation. To read the guideline in its entirety, visit www.rheumatology.org.

About the American College of Rheumatology
Headquartered in Atlanta, Ga., the American College of Rheumatology is an international medical society representing over 9,400 rheumatologists and rheumatology health professionals with a mission to Advance Rheumatology! In doing so, the ACR offers education, research, advocacy and practice management support to help its members continue their innovative work and provide quality patient care. Rheumatologists are experts in the diagnosis, management and treatment of more than 100 different types of arthritis and rheumatic diseases. For more information, visit www.rheumatology.org. 

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

About the ACR/ARHP Annual Meeting
The ACR/ARHP Annual Meeting is the premier rheumatology meeting for anyone involved in research or delivery of rheumatologic care or services. Each year, this event features the latest innovations, science, business and clinical best practices. For more information about the meeting, visit our website or join the conversation on Twitter by using the official #ACR15 hashtag.

Pages: 1 2 | Multi-Page

Filed Under: Conditions, From the College, Rheumatoid Arthritis

You Might Also Like:
  • 2015 ACR Guideline for the Treatment of Rheumatoid Arthritis
  • ACR Seeks Partners for Rheumatoid Arthritis Guideline Project
  • 2014 ACR/ARHP Annual Meeting: Rheumatoid Arthritis Management Treatment Recommendations
  • New Guideline for the Treatment of Psoriatic Arthritis

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.